Molecular Cardiology and Hypertension

Molecular cardiology could be a new space of cardiovascular drugs that aims to use molecular biological techniques for the mechanistic investigation, diagnosis, prevention, and treatment of heart failure As an rising discipline, it's modified our abstract thinking of cardiovascular development, sickness etiology, and pathophysiology. Although molecular cardiology continues to be at a awfully early stage, it's opened a promising avenue for understanding and dominant upset. A great interest of the laboratory is that the identification of novel current factors that regulate cardiac biology, as well as aging and hypertrophy.

Hypertension is that the single most vital risk issue for stroke. It causes about 50 per cent of ischemic strokes and also increases the risk of hemorrhagic stroke. The injury that high blood pressure causes happens over time and is commonly solely diagnosed once wide injury has already happened to the body’s blood vessels. The increase in vessel risk has primarily been delineated  in terms of elevated blood pressure in those over age sixty years and elevation in blood pressure in younger people.

    Related Conference of Molecular Cardiology and Hypertension

    April 10-11, 2025

    3rd World Congress on Quantum Physics

    Dubai, UAE
    April 22-23, 2025

    6th International Conference on Physics

    Paris, France
    June 24-25, 2025

    7th International Congress onPhysics

    Chicago, USA
    November 13-14, 2025

    18th International Conference on Optics, Photonics & Laser

    Aix-en-Provence, France

    Molecular Cardiology and Hypertension Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in